Legend Biotech Corporation Sponsored ADR (LEGN) reported $160.21 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 66.9%. EPS of -$0.34 for the same period compares to -$0.17 a year ago.The reported revenue represents a surprise of +10.72% over the Zacks Consensus Estimate of $144.7 million. With the consensus EPS estimate being -$0.56, the EPS surprise was +39.29%.While investors closely watch year-over-year changes in headline numbers -- revenue and earning ...